Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs. Propofol in High-Risk ERCP Patients
NCT07166614Completed
- Sponsor
- Şişli Hamidiye Etfal Training and Research Hospital
- Start
- Sep 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine (2 arms), sponsored by Şişli Hamidiye Etfal Training and Research Hospital. Primary endpoints: Heart Rate, Arterial Blood Pressure and 2 more. Started Sep 2025; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT07166614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07166614.